$RGC Defensive Stock to include in your Portfolio
Post# of 24966
(Total Views: 138)
Posted On: 11/28/2022 8:27:05 AM
$RGC Defensive Stock to include in your Portfolio (HEALTHCARE)
Investors and traders alike has seen stock market and crypto market tanked in the past several months due to multiple black swan events ie. Russian-Ukraine War, Fall of Luna/Terra, US Rate hikes, Surge in oil price, and amongst other things, INFLATION.
During this bear market, majority of stock companies and crypto prices have tank-ed, but there is a company that is currently showing resilience and is on an uptrend.
Regencell Bioscience Limited’s (NASDAQ:RGC) a bioscience and healthcare company which focuses heavily on R&D and commercialization of Traditional Chinese Medicine (TCM) treatment specifically ADHD and ASD, and infectious diseases targeting people’s immune system ie. COVID.
The stock price has seen 300% growth since IPO. The stock price has seen days of being shorted by traders in recent months. We will be monitoring these next few days if the stock price will rally to its previous ATH again.
The company's CEO (Mr. Yat-Gai Au), since IPO day has bought over $5 million of ordinary shares and has not sold any shares despite the having seen the stock price rose staggeringly. The company is currently in the business for the long run and will continue to be vested in its business model of developing treatments for AHDH and ASD as treatment trials are ongoing.
[https://www.valuewalk.com/game-stop-or-game-on-rgc-has-it-all-and-twice-more/]
Investors and traders alike has seen stock market and crypto market tanked in the past several months due to multiple black swan events ie. Russian-Ukraine War, Fall of Luna/Terra, US Rate hikes, Surge in oil price, and amongst other things, INFLATION.
During this bear market, majority of stock companies and crypto prices have tank-ed, but there is a company that is currently showing resilience and is on an uptrend.
Regencell Bioscience Limited’s (NASDAQ:RGC) a bioscience and healthcare company which focuses heavily on R&D and commercialization of Traditional Chinese Medicine (TCM) treatment specifically ADHD and ASD, and infectious diseases targeting people’s immune system ie. COVID.
The stock price has seen 300% growth since IPO. The stock price has seen days of being shorted by traders in recent months. We will be monitoring these next few days if the stock price will rally to its previous ATH again.
The company's CEO (Mr. Yat-Gai Au), since IPO day has bought over $5 million of ordinary shares and has not sold any shares despite the having seen the stock price rose staggeringly. The company is currently in the business for the long run and will continue to be vested in its business model of developing treatments for AHDH and ASD as treatment trials are ongoing.
[https://www.valuewalk.com/game-stop-or-game-on-rgc-has-it-all-and-twice-more/]
(0)
(0)Scroll down for more posts ▼